Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) Releases Earnings Results
Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) issued its quarterly earnings data on Monday. The company reported $0.06 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.06, Bloomberg Earnings reports. The firm had revenue of $29.70 million during the quarter, compared to analyst estimates of $27.84 million. The company’s quarterly revenue was up 32.6% compared to the same quarter last year.
Shares of Tabula Rasa Healthcare (TRHC) opened at 14.86 on Tuesday. The stock’s market cap is $255.86 million. Tabula Rasa Healthcare has a 1-year low of $10.39 and a 1-year high of $16.85. The stock’s 50 day moving average is $14.64 and its 200-day moving average is $14.00.
TRHC has been the subject of a number of analyst reports. Zacks Investment Research upgraded shares of Tabula Rasa Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, April 13th. Stifel Nicolaus cut their target price on shares of Tabula Rasa Healthcare from $19.00 to $16.00 and set a “buy” rating for the company in a research note on Tuesday, May 2nd. UBS AG reissued a “buy” rating and set a $17.00 target price (down previously from $18.00) on shares of Tabula Rasa Healthcare in a research note on Thursday, May 25th. Chardan Capital initiated coverage on shares of Tabula Rasa Healthcare in a research note on Monday, July 10th. They set a “buy” rating and a $19.50 target price for the company. Finally, Robert W. Baird boosted their target price on shares of Tabula Rasa Healthcare from $17.00 to $18.00 and gave the stock an “outperform” rating in a research note on Tuesday. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the company. Tabula Rasa Healthcare has an average rating of “Buy” and an average target price of $17.67.
In related news, Director Glen R. Bressner acquired 7,500 shares of Tabula Rasa Healthcare stock in a transaction that occurred on Thursday, May 18th. The stock was purchased at an average price of $11.96 per share, for a total transaction of $89,700.00. Following the completion of the purchase, the director now directly owns 18,256 shares of the company’s stock, valued at $218,341.76. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Orsula V. Knowlton sold 8,000 shares of the firm’s stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $11.94, for a total transaction of $95,520.00. Following the completion of the sale, the insider now owns 919,407 shares of the company’s stock, valued at approximately $10,977,719.58. The disclosure for this sale can be found here. Insiders sold 46,759 shares of company stock valued at $634,444 in the last quarter. Company insiders own 45.80% of the company’s stock.
WARNING: “Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) Releases Earnings Results” was first published by Daily Political and is the property of of Daily Political. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/08/tabula-rasa-healthcare-inc-nasdaqtrhc-releases-earnings-results.html.
About Tabula Rasa Healthcare
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.